Epstein Secrets

26.1M shares priced @ $23, M/a-com Technology (MTSI) 6M shares priced at $19 Key Research: JOY Key Research: (buy) Key Research: Key Research: Barcap upgrades UNP & downgrades NSC, GS downgrades WMS (sell), UBS downgrades Brean Murray downgrades HOGS, Jefferies downgrades XCO/DLR & upgrades AMD C

, fuel price to determine 2012 profit (trading -1.7%) F&C broadly inline, AUM -5% y/y already flagged with no new update provided (trading -1.2%) HeidelbergCement Q4 better, outlook good, hints at strong YTD in North America (trading +3%) H&M Feb sales figs ahead with comp sales positive for 3rd month in a ro

K) files for 15.75M shares IPO through Chardan Capital and Maxim Group, Black Knight Financial Services (BKFS) files $100M IPO US Key Research: .' Barcap initiates VA (ow), DB initiates VA (buy), MLB initiates EFC (hold) & HALO (buy) ••• Ladenberg downgrades MMM, Wells initiates ACAT (mp) Europe Key

conversion effective for taxable year beginning Jan 1 2015 • Novo Nordisk (NOVOB DC): Saxenda wins FDA approval to treat obesity (was expected) • HeidelbergCement sells Hanson Building Products unit for $1.4B to Lone Star Funds • Recticel (REC BB) large profit warning: sees 2014 combined Rebitda -12% y/y (tra

6.5M-shares priced at $11.50 US Key Research: ••• Mizuho upgrades MYGN (buy), Piper initiates CRI/PLCE (CRI), Citi upgrades AME (buy) & cuts IEX • Barcap upgrades BAX, Opco cuts CA/TWTC, Baird downgrades CMA, CLSA downgrades MDLZ ••• BB&T upgrades TREX (buy), Bernstein downgrades EMR & initiates ETN (

ated book build with UBS (trading -0.12%) • Standard Chartered IMS income better, indicated rev slowdown, FY guidance unchanged (trading -4.9%) • HeidelbergCement O1 revs & EBITDA slight below, sees "significant pretax improvement" (trading +-0.66%) • SAP sees $10 billion sales boost from banking services sof